OXFORD, UK / ACCESS Newswire / September 8, 2025 / Fine Treatment, a UK-based medical company, has unveiled new clinical evidence showing that its patented Thermobalancing therapy with Dr. Allen's Device provides safe and effective relief for men suffering from benign prostatic hyperplasia (BPH) and chronic prostatitis.
The findings confirm that Thermobalancing therapy directly addresses the underlying cause of prostate enlargement and inflammation, offering men a natural solution without the risks associated with conventional drug therapies.
"Our clinical studies demonstrated that Thermobalancing therapy is effective in relieving urinary symptoms caused by an enlarged prostate or chronic prostatitis," said Ariana Adjani, Co-founder of Fine Treatment. "Dr. Allen's Device is a safe, non-invasive intervention that men can use at home without worrying about harmful side effects."
Unlike prescription medications such as alpha blockers and 5-alpha-reductase inhibitors, which are linked to side effects including impotence, depression, and increased stroke risk, Dr. Allen's Device offers a cost-effective alternative priced under $200. The device has been shown to reduce prostate size naturally and improve lower urinary tract symptoms (LUTS), significantly enhancing men's quality of life.
Recognized as a Class I medical device, Dr. Allen's Device is approved for home use and is shipped worldwide by Fine Treatment via Royal Mail's tracked service.
About Fine Treatment
Based in Oxford, UK, Fine Treatment specializes in innovative natural medical solutions. With worldwide distribution, the company provides men with effective, drug-free therapies for BPH, chronic prostatitis, and chronic pelvic pain syndrome.
Media Contact:
Alex Day
Customer Service Manager
Fine Treatment, Oxford, London, United Kingdom
Tel: +44 7958 878300
Email: info@finetreatment.com
Website: www.finetreatment.com
SOURCE: Fine Treatment
View the original press release on ACCESS Newswire